First cases of deadly fungal infection reported in US: 8 things to know | 112 statistics on physicians under 45 years old – practice setting, finances, future plans & more | Nobilis’ Q3 revenue rallies 34.7%, losses total $2.8M – 13 key points | Medtronic teams with Masimo, 60+ others to eliminate preventable patient deaths by 2020: 6 takeaway


From: Becker's ASC Review <editorial@beckershealthcare.com>
Subject: First cases of deadly fungal infection reported in US: 8 things to know | 112 statistics on physicians under 45 years old - practice setting, finances, future plans & more | Nobilis' Q3 revenue rallies 34.7%, losses total $2.8M - 13 key points | Medtronic teams with Masimo, 60+ others to eliminate preventable patient deaths by 2020: 6 takeaway
Preheader:
Reply: editorial@beckershealthcare.com

TextView our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

               

                                               

                                  

                                                                 

Nov. 8, 2016

Today's Top Articles
1. Nobilis' Q3 revenue rallies 34.7%, losses total $2.8M - 13 key points  Full story  

2. First cases of deadly fungal infection reported in US: 8 things to know Full story

 

3. 112 statistics on physicians under 45 years old - practice setting, finances, future plans & more Full story 

 

4. Webinar: Medicare's Comprehensive Care for Joint Replacement and Episode Payment Model Programs - Lessons Learned from the Field. Register today!

5. Medtronic teams with Masimo, 60+ others to eliminate preventable patient deaths by 2020: 6 takeaways Full story 
   
6. 25 latest hospital, health system executive moves Full story 
 
7. Webinar: Post-operative Delirium: Quality of Life and Economic Implications to Patients and Hospitals. Click here to register.

8. Montecito Medical Real Estate to acquire neurology & orthopedic-focused ASC Full story 

9. 7 things for ASC leaders to know Full story


10. Valeant could sell Salix Pharmaceuticals to Takeda for $10B in cash grab: 7 things to know Full story 

                                                      
       
     

                                                                                                                        
                
 

Channels

_____________________
Contact Us

Editorial Contact:

Laura Dyrda  

Editor-in Chief
Becker's ASC Review
Becker's Spine Review
(312) 253-9170
email editorial  

Sales, Marketing & Events:
Jessica Cole
President and CEO

______________________

 


Becker's ASC | (800) 417-2035 | becker@beckersasc.com | http://www.beckersasc.com
17 N. State St.
Suite 1800
Chicago, IL 60602
Beckers ASC, 17 N. State St., Suite 1800, Chicago, IL 60602
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact